Metraipolis › archive › dc_cd2cb7a011bd

Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach — Europe PMC PMID:41600947

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41600947
DOI: 10.3390/vaccines14010031
License (as archived): solo-consultazione
Archived: 2026-11-07T09:23:45.132Z
SHA-256 of the archived text: 03ea0d2493c65ac3726db1730e409a353f673ed96f43528375bfff7c9e287e66
Stable URL of this page: https://metraipolis.com/documento/dc_cd2cb7a011bd

How to cite

Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach — Europe PMC PMID:41600947 — Europe PMC (en), https://europepmc.org/article/MED/41600947 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd2cb7a011bd (Metraipolis archive dc_cd2cb7a011bd, sha256 03ea0d2493c65ac3726db1730e409a353f673ed96f43528375bfff7c9e287e66)

BibTeX

@misc{dccd2cb7a011bd,
  title = {Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach — Europe PMC PMID:41600947},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41600947},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd2cb7a011bd; sha256 03ea0d2493c65ac3726db1730e409a353f673ed96f43528375bfff7c9e287e66},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41600947. Agents can read the archived copy with the MCP tool read_document.